HX575 Epoetin Alfa Subcutaneously (s.c.) in Chronic Kidney Disease (CKD)

PHASE3CompletedINTERVENTIONAL
Enrollment

417

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

June 30, 2015

Conditions
Chronic Kidney Disease
Interventions
DRUG

HX575 epoetin alfa (Sandoz)

Eligible patients are scheduled to receive HX575 (INN: Epoetin alfa) as a solution for injection in order to achieve or maintain the correction of renal anemia.

Trial Locations (50)

Unknown

Sandoz Investigative Site, Düsseldorf

Sandoz Investigative Site, Homberg (Efze)

Sandoz Investigative Site, Nettetal

Sandoz Investigative Site, Bari

Sandoz Investigative Site, Częstochowa

Sandoz Investigative Site, Gdansk

Sandoz Investigative Site, Gdynia

Sandoz Investigative Site, Olkusz

Sandoz Investigative Site, Poznan

Sandoz Investigative Site, Płock

Sandoz Investigative Site, Wadowice

Sandoz Investigative Site, Warzawa

Sandoz Investigative Site, Bucharest

Sandoz Investigative Site, Constanța

Sandoz Investigative Site, Lasi

Sandoz Investigative Site, Oradea

Sandoz Investigative Site, Timișoara

Sandoz Investigative Site, Chelyabinsk

Sandoz Investigative Site, Kemerovo

Sandoz Investigative Site, Kolomna

Sandoz Investigative Site, Moscow

Sandoz Investigative Site, Mytischi

Sandoz Investigative Site, Nizhny Novgorod

Sandoz Investigative Site, Novosibirsk

Sandoz Investigative Site, Orenburg

Sandoz Investigative Site, Petrozavodsk

Sandoz Investigative Site, Podolsk

Sandoz Investigative Site, Pyatigorsk

Sandoz Investigative Site, Ryazan

Sandoz Investigative Site, Saint Petersburg

Sandoz Investigative Site, Saratov

Sandoz Investigative Site, Smolensk

Sandoz Investigative Site, Yaroslavl

Sandoz Investigative Site, Yekaterinburg

Sandoz Investigative Site, Adana

Sandoz Investigative Site, Ankara

Sandoz Investigative Site, Istanbul

Sandoz Investigative Site, Chernivtsi

Sandoz Investigative Site, Dnipropetrovsk

Sandoz Investigative Site, Donetsk

Sandoz Investigative Site, Ivano-Frankivsk

Sandoz Investigative Site, Kharkiv

Sandoz Investigative Site, Kyiv

Sandoz Investigative Site, Luhansk

Sandoz Investigative Site, Mykolayiv

Sandoz Investigative Site, Poltava

Sandoz Investigative Site, Ternopil

Sandoz Investigative Site, Uzhhorod

Sandoz Investigative Site, Zaporizhya

Sandoz Investigative Site, Zhitomyr

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sandoz

INDUSTRY

NCT01576341 - HX575 Epoetin Alfa Subcutaneously (s.c.) in Chronic Kidney Disease (CKD) | Biotech Hunter | Biotech Hunter